Pharmabiz8 m
Organon India appoints Vivek Soares as its new country lead for India and South Asia
Organon India announces the appointment of Vivek Soares as its new country lead for India and South Asia, commencing on June 1, 2024. Soares will take the reins from Anjan Sen, who will retire after ...
Pharmabiz1 h
Bayer collaborates with Samsung to address data gaps on sleep disturbances associated with menopause
Bayer AG announced a strategic collaboration with Samsung Electronics America, Inc. to address data gaps on sleep disturbances associated with menopause (SDM). The companies will co-develop an ...
Pharmabiz2 h
EMA committee recommends approval of AstraZeneca’s Tagrisso with the addition of chemotherapy for patients with EGFR-mutated advanced lung cancer
EMA committee recommends approval of AstraZeneca’s Tagrisso with the addition of chemotherapy for patients with EGFR-mutated advanced lung cancer ...
Pharmabiz2 h
Philogen, Sun Pharma seek European marketing approval for Nidlegy to treat neoadjuvant locally advanced fully resectable melanoma
Philogen S.p.A. (BITHIL) and Sun Pharmaceutical Industries Limited announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for the approval of ...
Pharmabiz3 h
Bio-Thera Solutions gets positive CHMP opinion for Avzivi, a biosimilar referencing Avastin
Bio-Thera Solutions gets positive CHMP opinion for Avzivi, a biosimilar referencing Avastin: Guangzhou, China Tuesday, June 4, 2024, 14:00 Hrs [IST] Bio-Thera Solutions Inc., a co ...
Pharmabiz3 h
Gujarat FDCA cancels licenses of 276 retailers & suspends licenses of 119 retailers for violation of norms
In a massive crackdown on the illegal and clandestine supply chain of narcotic drugs and spurious drugs in the state, the Gujarat Food and Drug Control Administration (FDCA) has suspended licenses of ...
Pharmabiz3 h
Despite challenges, CAM therapies hold immense promise for enhancing healthcare outcomes: Expert
Despite challenges including lack of standardization and regulation across various Complementary and Alternative Medicine (CAM) therapies, the ongoing advancement and integration of CAM therapies hold ...
Pharmabiz4 h
Dizal’s pivotal WU-KONG1B study of sunvozertinib in relapsed or refractory NSCLC with EGFR exon 20 insertion mutations meets primary endpoint
Dizal, a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, presented the latest data from the inaugural global pivotal study ...
Pharmabiz5 h
Aurigene opens biologics facility in Genome Valley for process development and clinical scale manufacturing capabilities
Aurigene opens biologics facility in Genome Valley for process development and clinical scale manufacturing capabilities: Our Bureau, Bengaluru Tuesday, June 4, 2024, 11:15 Hrs [I ...
Pharmabiz8 h
BD to buy Edwards Lifesciences' Critical Care product group for $4.2 billion
BD (Becton, Dickinson and Company), a leading global medical technology company, and Edwards Lifesciences announced a definitive agreement under which BD will acquire Edwards' Critical Care product ...
Pharmabiz9 h
IMPCOPS at Adayar in Chennai crying for govt support for existence
IMPCOPS at Adayar in Chennai crying for govt support for existence: Peethaambaran Kunnathoor, Chennai Tuesday, June 4, 2024, ...
Pharmabiz9 h
US FDA guidance on formulation development to bolster opportunities for Indian companies
US FDA guidance on formulation development to bolster opportunities for Indian companies: Nandita Vijayasimha, Bengaluru Tuesday, June 4, 2024, 08:00 Hrs [IST] Indian pharma’s g ...